Navigation Links
Echo Therapeutics Reports Third Quarter 2007 Results
Date:11/20/2007

488,650 103,365

Total current liabilities 915,248 284,823

Notes Payable, net of current portion - 54,508

Commitments

Stockholders' Equity

Series A Convertible Preferred Stock,

$0.01 par value, authorized

7,000,000 shares, issued and

outstanding no shares at

September 30, 2007 and 73,334

shares at December 31, 2006 - 76,291

Common stock, $0.01 par value,

authorized 60,000,000 shares,

issued and outstanding

17,707,679 shares at September

30, 2007 and 2,776,192 shares

at December 31, 2006 177,079 27,762

Additional paid-in capital 56,494,899 34,822,306

Accumulated deficit (44,738,545) (34,460,661)

Total stockholders' equity 11,933,433 465,698

Total liabilities and

stockholders' equity $12,848,681 $805,029

Echo Therapeutics, Inc.

(Formerly Sontra Medical Corporation)

Consolidated Statements of Operations

(Unaudited)

Three Months Ended Nine Months Ended

September 30, September 30,

2007 2006 2007 2006

Revenue:

Product revenues $ - $10,679 $12,120 $37,619

Licensing revenue 12,500 12,500 37,500 37,501

Total revenue 12,500 23,179 49,620 75,120

Operating Expenses:

Cost of product

revenue - 9,445 1,556 61,734

Research and

development
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... August 28, 2014 Supplementing their ... a promotion for Eppendorf Safe Lock Centrifuge ... purchase the highest quality tubes at an affordable ... for customers doing chemical, medical, pharmaceutical, and life ... are not regularly able to afford Eppendorf products. ...
(Date:8/27/2014)... -- Rhythm, a biopharmaceutical company developing peptide therapeutics that ... metabolic disorders, announced today that it has filed a ... and Exchange Commission (SEC) relating to the proposed initial ... number of shares to be offered and the price ... Citigroup and Cowen and Company will act ...
(Date:8/27/2014)... is how plants survive impact by the huge ... while using this energy for photosynthesis. The hypothesis ... blades quickly dissipate the energy throughout the entire ... DTU Physics have now managed to successfully ,film, ... contain light-absorbing proteins which play a role in ...
(Date:8/27/2014)... 2014  Lisa Kulik saw fireworks for the first ... thanks to a groundbreaking retinal implant co-invented by ... at the University of Southern California (USC) Eye Institute. ... Ariz. resident who has retinitis pigmentosa, a ... On June 2, she became the first person west ...
Breaking Biology Technology:Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2DTU researchers film protein quake for the first time 2USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 2USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 3USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 4USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 5
... 7 Abbott (NYSE: ABT ),will present ... on Tuesday, March 18, 2008. Thomas C. Freyman, ... make a formal,presentation on the company at 8:30 ... of the presentation will be accessible through,Abbott,s Investor ...
... On Thursday, March 13, 2008,at 8:30 a.m. ... Therapeutics, Inc.,s (CTI) (Nasdaq: CTIC ; MTAX) ... discuss the company,s 2007 fourth,quarter achievements and year-end ... Thursday, March 13 8:30 a.m. Eastern/1:30 p.m. ...
... team of researchers from the departments of macromolecular science ... of Engineering and the Louis Stokes Cleveland Department of ... a new type of polymer that displays chemoresponsive mechanic ... to soft plastic and vice versa in seconds when ...
Cached Biology Technology:Researchers engineer new polymers to change their stiffness and strength when exposed to liquids 2Researchers engineer new polymers to change their stiffness and strength when exposed to liquids 3
(Date:8/27/2014)... listen carefully to someone, the first thing we do ... stop moving altogether. This strategy helps us hear better ... , This interplay between movement and hearing also has ... has long suggested that the brain,s motor cortex, which ... rise to our conscious perception of sound. , A ...
(Date:8/27/2014)... beasts. But every creature is a baby once. , ... of 24 very young dinosaurs and one older individual ... a caretaker, according to a new study by University ... Peter Dodson led the work, collaborating with researchers from ... is held. Hedrick is a doctoral student in the ...
(Date:8/27/2014)... evidence puts into doubt the long-standing belief that a ... brain plays a central role in depression. In ... that mice lacking the ability to make serotonin in ... conventional wisdom) did not show depression-like symptoms. , ... VA Medical Center and Wayne State University School of ...
Breaking Biology News(10 mins):Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 2Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 3New study throws into question long-held belief about depression 2
... States are markedly underestimating the changes needed to mitigate ... change because they work in ,silos, according to pioneering ... Manchester, discovered that the lack of communication between government ... differences over who is responsible for what. He ...
... fibrillation is a cardiac arrhythmia a chronic irregularity ... people in Germany. Although the condition is not acutely ... serious illnesses, such as cardiac insufficiency, stroke and dementia. ... studies, an international team of researchers, led by LMU ...
... as the "world,s aquarium," the marine ecosystems of the ... methods are depleting the sea,s habitats, creating areas that ... story "Threatened Gulf" . But, as Octavio ... Diego will describe during a presentation at the 2010 ...
Cached Biology News:Governments 'misjudging' scale of CO2 emissions 2When the heart gets out of step 2When the heart gets out of step 3Damage to threatened Gulf of California habitats can be reversed 2
...
...
... Solid phase reagent ... purification; Easy & unique ... Compatible with detergents and ... & recover non-envelop viruses ...
Synaptic Vesicle I Sampler Kit 10g each...
Biology Products: